16:27 EST Psyence Biomedical (PBM) files to sell 10.9M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBM:
- Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health
- Psyence Biomedical Advances in Phase IIb Psilocybin Clinical Trial
- Psyence Biomedical highlights progress on Phase IIb clinical trial
- Rising High: Organigram acquires Motif Labs for C$90M upfront
- Psyence Biomedical executes binding agreements with Optimi Health